Enfusion Q4 2024 Earnings Report
Key Takeaways
Enfusion reported a 13.9% increase in total revenue, reaching $52.9 million for Q4 2024. The company's net income was $0.2 million, and adjusted EBITDA grew by 25.3% to $12.3 million. Enfusion also announced its entry into a definitive agreement to be acquired by Clearwater Analytics, expected to close in the second quarter of 2025.
Total revenue increased by 13.9% year-over-year to $52.9 million.
Net income was $0.2 million, with a net income margin of 0.3%.
Adjusted EBITDA rose by 25.3% year-over-year to $12.3 million.
Enfusion entered into an agreement to be acquired by Clearwater Analytics, anticipated to close in Q2 2025.
Enfusion
Enfusion
Enfusion Revenue by Segment
Forward Guidance
Enfusion will not be hosting an earnings conference call, releasing a Shareholder Letter, or providing financial guidance for fiscal 2025 due to the announced transaction with Clearwater Analytics.